Trade Summary

4 months ago, Gallagher Cam, serving as Dir at Opus Genetics, Inc. (IRD), purchased 164,000 shares at $1.97 per share, for a total transaction value of $323,693.00. Following this transaction, Gallagher Cam now holds 2,007,430 shares of IRD.

This purchase represents a 9.00% increase in Gallagher Cam's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, December 29, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, December 31, 2025 at 4:33 PM ET, 2 days after the trade was made.

Opus Genetics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.